Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06388460 · ClinicalTrials.gov registry record · NA

Asthma Link Effectiveness Trial

A NA study of Childhood Asthma, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT06388460: Recruiting NA study of Childhood Asthma, sponsored by University of Massachusetts, Worcester.

NCT06388460 is a NA study of Childhood Asthma that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 350 participants, above the 141-participant average among 4 other Childhood Asthma trials with a reported enrollment target (148% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06388460, a NA study of Childhood Asthma, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma workbook, in improving asthma symptoms for children with poorly controlled asthma aged 5-14.

Primary Outcome

Asthma Control Test to measure child's asthma control on a scale of 0-25. A score of 19 or less is considered poorly controlled asthma.

Conditions Studied

Interventions

  • OTHER Enhanced Usual Care
  • OTHER Asthma Link

Study Locations (1)

Massachusetts

  • University of Massachusetts Chan Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-04-04
Est. Completion 2028-04
Phase NA

What NCT06388460 shows while recruiting

NCT06388460 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 141-participant average among 4 other Childhood Asthma trials with a reported enrollment target (148% higher).

The record links to 1 condition, with Childhood Asthma appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06388460 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06388460 about?

NCT06388460 is a clinical study titled "Asthma Link Effectiveness Trial". The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma workbook, in improving asthma symptoms for children with poorly controlled asthma aged 5-14.

What is the current status of trial NCT06388460?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-04-04. Estimated completion is 2028-04.

What conditions does trial NCT06388460 study?

This clinical trial studies the following conditions: Childhood Asthma.

What interventions are being tested in trial NCT06388460?

The interventions under investigation include: Enhanced Usual Care (OTHER), Asthma Link (OTHER).

Who is sponsoring clinical trial NCT06388460?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06388460 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06388460, the US trial registry maintained by the National Library of Medicine. NCT06388460 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.